Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could have a ...

Apple's latest developer beta adds AI-generated Apple Music playlists, early testing for encrypted RCS messaging and a new setting to tone down iOS 26's brighter visual effects With more than a decade ...

Feb. 27, 2026 Scientists have unveiled a breakthrough way to turn natural gas—long burned as fuel—into valuable chemical building blocks for medicines and other high-demand products. By designing a ...

Michelle is a lead editor at Forbes Advisor. She has been a journalist for over 35 years, writing about insurance for consumers for the last decade. Prior to covering insurance, Michelle was a ...